{"id":1499,"date":"2026-11-05T13:34:57","date_gmt":"2026-11-05T12:34:57","guid":{"rendered":"https:\/\/epilogy.org\/?p=1499"},"modified":"2026-11-05T13:44:38","modified_gmt":"2026-11-05T12:44:38","slug":"jdp-2026","status":"publish","type":"post","link":"https:\/\/epilogy.org\/fr\/jdp-2026","title":{"rendered":"JDP 2026"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"1499\" class=\"elementor elementor-1499 elementor-bc-flex-widget\">\n\t\t\t\t<div class=\"elementor-element elementor-element-367c91a e-flex e-con-boxed e-con e-parent\" data-id=\"367c91a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5f22ccf elementor-widget elementor-widget-html\" data-id=\"5f22ccf\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t<style>\n.epilogy-news{\nbackground:#ffffff;\nborder:1px solid #ead3ee;\nborder-radius:8px;\npadding:24px;\nmargin:24px 0;\nfont-size:13px;\ncolor:#54595F;\nline-height:1.7;\nbox-shadow:0 2px 8px rgba(0,0,0,0.04);\n}\n\n.epilogy-news-header{\ndisplay:grid;\ngrid-template-columns:110px 1fr;\ngap:18px;\nalign-items:center;\npadding-bottom:18px;\nmargin-bottom:18px;\n}\n\n.epilogy-news-header img{\nwidth:110px;\nheight:110px;\nobject-fit:cover;\nborder-radius:100%;\ntransition:all .2s ease;\n}\n\n.epilogy-news-header img:hover{\ntransform:scale(1.03);\n}\n\n.epilogy-news-title{\nfont-size:22px;\nline-height:1.3;\nfont-weight:700;\ncolor:#7C2A86;\nmargin:0 0 8px 0;\n}\n\n.epilogy-news-subtitle{\nfont-size:13px;\ncolor:#777;\nmargin:0;\n}\n\n.epilogy-news-content{\nmargin:0 0 18px 0;\n}\n\n.epilogy-news-content p{\nmargin:0 0 14px 0;\n}\n\n.epilogy-news-content p:last-child{\nmargin-bottom:0;\n}\n\n.epilogy-news-highlight{\nbackground:#FADFFF;\npadding:16px;\nborder-radius:6px;\nmargin:20px 0;\nborder-left:4px solid #7C2A86;\ndisplay:grid;\ngrid-template-columns:90px 1fr;\ngap:14px;\nalign-items:center;\n}\n\n.epilogy-news-highlight img{\nwidth:90px;\nheight:90px;\nobject-fit:cover;\nborder-radius:100%;\n}\n\n.epilogy-news-highlight strong{\ncolor:#7C2A86;\n}\n\n.epilogy-news-button-wrap{\ntext-align:center;\nmargin-top:16px;\n}\n\n.epilogy-news-button{\ndisplay:inline-block;\nbackground:#7C2A86;\ncolor:#ffffff !important;\ntext-decoration:none;\npadding:10px 18px;\nborder-radius:30px;\nfont-size:12px;\nfont-weight:600;\ntransition:all .2s ease;\n}\n\n.epilogy-news-button:hover{\nopacity:.9;\ntransform:translateY(-1px);\n}\n\n@media(max-width:680px){\n\n.epilogy-news-header{\ngrid-template-columns:1fr;\ntext-align:center;\n}\n\n.epilogy-news-header img{\nmargin:0 auto;\n}\n\n.epilogy-news-highlight{\ngrid-template-columns:1fr;\ntext-align:center;\n}\n\n.epilogy-news-highlight img{\nmargin:0 auto;\n}\n\n}\n\n.jdp-day{\nposition:relative;\npadding-left:26px;\nmargin:22px 0 0 0;\nborder-left:2px solid #ead3ee;\n}\n\n.jdp-day::before{\ncontent:\"\";\nposition:absolute;\nleft:-8px;\ntop:4px;\nwidth:14px;\nheight:14px;\nborder-radius:50%;\nbackground:#7C2A86;\n}\n\n.jdp-day-title{\nmargin:0 0 12px 0;\ncolor:#7C2A86;\nfont-size:16px;\nfont-weight:700;\n}\n\n.jdp-session{\nmargin:0 0 16px 0;\n}\n\n.jdp-session-title{\nmargin:0 0 8px 0;\nfont-weight:600;\ncolor:#54595F;\nfont-size:13px;\ntext-transform:none;\n}\n\n.jdp-session-title span{\ndisplay:inline-block;\nmargin-left:6px;\npadding:1px 10px;\nborder-radius:20px;\nbackground:#FADFFF;\ncolor:#7C2A86;\nfont-size:12px;\nfont-weight:600;\n}\n\n.jdp-talk{\ndisplay:grid;\ngrid-template-columns:auto 1fr;\ngap:14px;\nalign-items:center;\nbackground:#FDF7FF;\nborder:1px solid #FADFFF;\nborder-radius:6px;\npadding:12px 14px;\nmargin:0 0 8px 0;\n}\n\n.jdp-talk-noavatar{\ngrid-template-columns:1fr;\n}\n\n.jdp-talk strong{\ncolor:#7C2A86;\n}\n\n.jdp-avatars{\ndisplay:flex;\ngap:6px;\n}\n\n.jdp-avatar{\nwidth:56px;\nheight:56px;\nborder-radius:50%;\nobject-fit:cover;\nflex-shrink:0;\n}\n\n.jdp-initials{\ndisplay:flex;\nalign-items:center;\njustify-content:center;\nbackground:#e9d6ef;\ncolor:#7C2A86;\nfont-weight:600;\nfont-size:15px;\n}\n\n.jdp-time{\ndisplay:block;\nfont-size:12px;\nfont-weight:600;\ncolor:#777;\n}\n\n@media(max-width:680px){\n.jdp-day{padding-left:16px;}\n.jdp-talk{grid-template-columns:1fr;}\n}\n<\/style>\n\n<div class=\"epilogy-news\">\n\n<div class=\"epilogy-news-header\" style=\"grid-template-columns:1fr;\">\n\n<div>\n<h2 class=\"epilogy-news-title\">JDP 2026 \u2013 L'\u00e9quipe Epilogy aux Journ\u00e9es dermatologiques de Paris<\/h2>\n<p class=\"epilogy-news-subtitle\">Communications orales et FMC au grand rendez-vous de la dermatologie fran\u00e7aise<\/p>\n<\/div>\n<\/div>\n\n<div class=\"epilogy-news-content\">\n\n<p>\nLes Journ\u00e9es dermatologiques de Paris (JDP), grand rendez-vous annuel de la dermatologie fran\u00e7aise, se tiendront du 1er au 5 d\u00e9cembre 2026 au Palais des Congr\u00e8s (Porte Maillot, Paris). Elles r\u00e9unissent dermatologues, chercheurs et professionnels de sant\u00e9 autour des derni\u00e8res avanc\u00e9es scientifiques et cliniques.\n<\/p>\n\n<p>\nLes membres de l'\u00e9quipe Epilogy seront pr\u00e9sents tout au long de cette \u00e9dition 2026 pour pr\u00e9senter des communications orales, issues notamment d'\u00e9tudes men\u00e9es \u00e0 partir du Syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS), et pour animer une session de formation m\u00e9dicale continue (FMC) consacr\u00e9e aux revues syst\u00e9matiques incontournables de l'ann\u00e9e.\n<\/p>\n\n<p>\nRetrouvez ci-dessous toutes les interventions de l'\u00e9quipe Epilogy :\n<\/p>\n\n<\/div>\n\n<div class=\"jdp-day\">\n<h3 class=\"jdp-day-title\">Mercredi 2 d\u00e9cembre<\/h3>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">Dermatoses infectieuses <span>14h15 \u2013 15h45<\/span><\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/Robin_Arcani.png\" alt=\"Robin Arcani\"><\/div>\n<div>\n<span class=\"jdp-time\">14h35 \u2013 14h45<\/span>\n<strong>Robin Arcani<\/strong><br>\nRisque d\u2019infections s\u00e9v\u00e8res sous anti-TNF chez les patients atteints de sarco\u00efdose : une \u00e9tude de cohorte nationale expos\u00e9e\/non expos\u00e9e \u00e0 partir du syst\u00e8me national des donn\u00e9es de sant\u00e9\n<\/div>\n<\/div>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><span class=\"jdp-avatar jdp-initials\">VF<\/span><\/div>\n<div>\n<span class=\"jdp-time\">14h45 \u2013 14h55<\/span>\n<strong>Vanessa Feracin<\/strong><br>\nImpact de l\u2019initiation d\u2019une bioth\u00e9rapie sur le parcours de soins et la consommation d\u2019antibiotiques dans l'hidrad\u00e9nite suppur\u00e9e : cohorte nationale de 7651 patients \u00e0 partir du Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS)\n<\/div>\n<\/div>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/Mounya-Abboud-min.png\" alt=\"Mounya Abboud\"><\/div>\n<div>\n<span class=\"jdp-time\">14h55 \u2013 15h05<\/span>\n<strong>Mounya Abboud<\/strong><br>\nRisque de zona sous th\u00e9rapies cibl\u00e9es des maladies inflammatoires immunom\u00e9di\u00e9es : \u00e9tude de cohorte nationale comparative\n<\/div>\n<\/div>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><span class=\"jdp-avatar jdp-initials\">HL<\/span><\/div>\n<div>\n<span class=\"jdp-time\">15h05 \u2013 15h15<\/span>\n<strong>Hugo Lemerre<\/strong><br>\nDermatoses lich\u00e9no\u00efdes graves sous inhibiteurs de checkpoint immunitaire : impact sur la prise en charge oncologique ult\u00e9rieure\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">Toxidermies<\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/Quentin_Samaran.jpg\" alt=\"Quentin Samaran\"><\/div>\n<div>\n<span class=\"jdp-time\">15h25 \u2013 15h35<\/span>\n<strong>Quentin Samaran<\/strong><br>\nEffets ind\u00e9sirables immuno-m\u00e9di\u00e9s s\u00e9v\u00e8res des anti-PD-1 dans la prise en charge des carcinomes \u00e9pidermo\u00efdes cutan\u00e9s avanc\u00e9s : \u00e9tude de cohorte nationale sur la base de donn\u00e9es de l'Assurance Maladie (\u00e9tude CEc-iTox)\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jdp-day\">\n<h3 class=\"jdp-day-title\">Jeudi 3 d\u00e9cembre<\/h3>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">Session Allergologie <span>09h00 \u2013 10h30<\/span><\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><span class=\"jdp-avatar jdp-initials\">HW<\/span><\/div>\n<div>\n<span class=\"jdp-time\">10h20 \u2013 10h30<\/span>\n<strong>H\u00e9lo\u00efse Wauquiez<\/strong><br>\nComparaison de la persistance du Tralokinumab et des JAKi apr\u00e8s \u00e9chec du Dupilumab dans le traitement de la dermatite atopique, \u00e0 partir d\u2019une cohorte nationale (projet DATOP)\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">FMC <span>16h15 \u2013 17h45<\/span><\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/laurence_le_cleach-min-MAJ.png\" alt=\"Laurence Le Cleach\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/emilie-sbidian-min.png\" alt=\"Emilie Sbidian\"><\/div>\n<div>\n\n<strong>Laurence Le Cleach (coordinatrice), Emilie Sbidian (oratrice)<\/strong><br>\n10 revues syst\u00e9matiques de 2026 incontournables pour ma pratique\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jdp-day\">\n<h3 class=\"jdp-day-title\">Vendredi 4 d\u00e9cembre<\/h3>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">Dermatologie p\u00e9diatrique - G\u00e9n\u00e9tique<\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/thomas-betuzzi-min-500x500-1.png\" alt=\"Thomas Bettuzzi\"><\/div>\n<div>\n<span class=\"jdp-time\">10h10 \u2013 10h20<\/span>\n<strong>Thomas Bettuzzi<\/strong><br>\nEsp\u00e9rance de vie et risque de d\u00e9c\u00e8s chez les patients atteints de neurofibromatose de type 1 : \u00e9tude de cohorte de 1980 \u00e0 2025\n<\/div>\n<\/div>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/thomas-betuzzi-min-500x500-1.png\" alt=\"Thomas Bettuzzi\"><\/div>\n<div>\n<span class=\"jdp-time\">10h20 \u2013 10h30<\/span>\n<strong>Thomas Bettuzzi<\/strong><br>\nIncidence et pronostic des complications de la neurofibromatose de type 1 : une \u00e9tude de 22157 patients \u00e0 partir des donn\u00e9es du Syst\u00e8me national des donn\u00e9es de Sant\u00e9\n<\/div>\n<\/div>\n<\/div>\n<div class=\"jdp-session\">\n<p class=\"jdp-session-title\">Dermatoses bulleuses<\/p>\n<div class=\"jdp-talk\">\n<div class=\"jdp-avatars\"><img decoding=\"async\" class=\"jdp-avatar\" src=\"https:\/\/epilogy.org\/wp-content\/uploads\/2026\/03\/thomas-betuzzi-min-500x500-1.png\" alt=\"Thomas Bettuzzi\"><\/div>\n<div>\n<span class=\"jdp-time\">15h35 \u2013 15h45<\/span>\n<strong>Thomas Bettuzzi<\/strong><br>\nFacteurs pr\u00e9dictifs de rechute tardive du pemphigus apr\u00e8s rituximab : \u00e9tude r\u00e9trospective monocentrique de 62 patients\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n<div class=\"epilogy-news-button-wrap\">\n<a href=\"https:\/\/www.lesjdp.fr\" target=\"_blank\" class=\"epilogy-news-button\">\nVisiter le site des JDP 2026\n<\/a>\n<\/div>\n\n<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>JDP 2026 \u2013 The Epilogy Team at the Journ\u00e9es Dermatologiques de Paris Oral communications and a CME session at the major French dermatology meeting The Journ\u00e9es Dermatologiques de Paris (JDP), the major annual meeting of French dermatology, will take place from December 1 to 5, 2026, at the Palais des Congr\u00e8s (Porte Maillot, Paris). They&hellip;&nbsp;<a href=\"https:\/\/epilogy.org\/fr\/jdp-2026\" rel=\"bookmark\"><span class=\"screen-reader-text\">JDP 2026<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":1498,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","neve_meta_reading_time":"","footnotes":""},"categories":[18],"tags":[],"class_list":["post-1499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-epinews"],"_links":{"self":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/comments?post=1499"}],"version-history":[{"count":5,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1499\/revisions"}],"predecessor-version":[{"id":1504,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/posts\/1499\/revisions\/1504"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/media\/1498"}],"wp:attachment":[{"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/media?parent=1499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/categories?post=1499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/epilogy.org\/fr\/wp-json\/wp\/v2\/tags?post=1499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}